Volumenmanagement bei Sepsis und septischer Schock

Matthias Kochanek; Boris Böll

doi:10.1055/s-0043-110020

DMW - Deutsche Medizinische Wochenschrift, Inhaltsverzeichnis

Dtsch Med Wochenschr 2018; 143(14): 1039-1049
DOI: 10.1055/s-0043-110020

CME-Fortbildung

Volumenmanagement bei Sepsis und septischer Schock

Fluid Resuscitation and Management in Patients with Sepsis and Septic Shock

Matthias Kochanek

,

Boris Böll

Abstract

Sepsis and septic shock are common diseases with high mortality rates. Although volume therapy has been a central component of sepsis therapy for decades, the choice of optimal fluid and fluid intake is unclear. This paper summarizes findings on pathophysiology, clinical trial results, and current recommendations for optimal volume and fluid management in sepsis.

Sepsis und septischer Schock sind häufige Krankheitsbilder mit unverändert hoher Mortalität. Obwohl die Volumentherapie seit Jahrzehnten zentraler Bestandteil der Sepsistherapie ist, ist die Wahl der optimalen Flüssigkeit und Menge der Flüssigkeitszufuhr ungeklärt. Dieser Beitrag fasst Erkenntnisse zur Pathophysiologie, Ergebnisse klinischer Studien und aktuelle Empfehlungen zum optimalen Volumen- und Flüssigkeitsmanagement bei Sepsis zusammen.

Schlüsselwörter

Sepsis - Flüssigkeitsmanagement - septischer Schock - Organdysfunktion

Key words

sepsis - fluid management - septic shock - organ dysfunction

Volltext

Referenzen

Literatur
1 Singer M, Deutschman CS, Seymour CW. et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA 2016; 315: 801-810 . doi:10.1001/jama.2016.0287
2 Vincent JL, Martin GS, Levy MM. qSOFA does not replace SIRS in the definition of sepsis. Crit Care 2016; 20: 210 . doi:10.1186/s13054-016-1389-z
3 Martin GS, Mannino DM, Eaton S. et al. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003; 348: 1546-1554 . doi:10.1056/NEJMoa022139
4 Vincent JL, Sakr Y, Sprung CL. et al. Sepsis in European intensive care units: Results of the SOAP study. Crit Care Med 2006; 34: 344-353 . doi:10.1097/01.CCM.0000194725.48928.3A
5 Fleischmann C, Thomas-Rueddel DO, Hartmann M. et al. Hospital incidence and mortality rates of sepsis. Dtsch Arztebl Int 2016; 113: 159-166 . doi:10.3238/arztebl.2016.0159
6 Thijs LG, Schneider AJ, Groeneveld AB. The haemodynamics of septic shock. Intensive Care Med 1990; 16 (03) S182-S186
7 Kakihana Y, Ito T, Nakahara M. et al. Sepsis-induced myocardial dysfunction: pathophysiology and management. J Intensive Care 2016; 4: 22 . doi:10.1186/s40560-016-0148-1
8 Russell JA, Rush B, Boyd J. Pathophysiology of septic shock. Crit Care Clin 2018; 34: 43-61 . doi:10.1016/j.ccc.2017.08.005
9 Cobb JP, Danner RL. Nitric oxide and septic shock. JAMA 1996; 275: 1192-1196
10 Zardi EM, Zardi DM, Dobrina A. et al. Prostacyclin in sepsis: a systematic review. Prostaglandins Other Lipid Mediat 2007; 83: 1-24 . doi:10.1016/j.prostaglandins.2006.12.004
11 Bernard GR, Wheeler AP, Russell JA. et al. The effects of ibuprofen on the physiology and survival of patients with sepsis. N Engl J Med 1997; 336: 912-918 . doi:10.1056/NEJM199703273361303
12 Wagner K, Wachter U, Vogt JA. et al. Adrenomedullin binding improves catecholamine responsiveness and kidney function in resuscitated murine septic shock. Intensive Care Med Exp 2013; 1: 21 . doi:10.1186/2197-425X-1-2
13 Rivers E, Nguyen B, Havstad S. et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001; 345: 1368-1377 . doi:10.1056/NEJMoa010307
14 Lilly CM. The ProCESS Trial – A new era of sepsis management. N Engl J Med 2014; 370: 1750-1751 . doi:10.1056/NEJMe1402564
15 Maitland K, Kiguli S, Opoka RO. et al. Mortality after fluid bolus in African children with severe infection. N Engl J Med 2011; 364: 2483-2495 . doi:10.1056/NEJMoa1101549
16 Byrne L, Van Haren F. Fluid resuscitation in human sepsis: Time to rewrite history?. Ann Intensive Care 2017; 7: 4 . doi:10.1186/s13613-016-0231-8
17 Rhodes A, Evans LE, Alhazzani W. et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016. Intensive Care Med 2017; 43: 304-377 . doi:10.1007/s00134-017-4683-6
18 Marx G. S3-Leitlinie Intravasale Volumentherapie beim Erwachsenen. 2014 AWMF Registernummer 001–020. Im Internet: http://www.awmf.org/leitlinien/detail/ll/001-020.html ; Stand: 05.06.2018
19 Monnet X, Marik PE, Teboul JL. Prediction of fluid responsiveness: an update. Ann Intensive Care 2016; 6: 111 . doi:10.1186/s13613-016-0216-7
20 Marik PE, Cavallazzi R. Does the central venous pressure predict fluid responsiveness? An updated meta-analysis and a plea for some common sense. Crit Care Med 2013; 41: 1774-1781 . doi:10.1097/CCM.0b013e31828a25fd
21 Rhodes A, Evans LE, Alhazzani W. et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016. Crit Care Med 2017; 45: 486-552 . doi:10.1097/CCM.0000000000002255
22 Cecconi M, De Backer D, Antonelli M. et al. Consensus on circulatory shock and hemodynamic monitoring. Task force of the European Society of Intensive Care Medicine. Intensive Care Med 2014; 40: 1795-1815 . doi:10.1007/s00134-014-3525-z
23 Saugel B, Huber W, Nierhaus A. et al. Advanced hemodynamic management in patients with septic shock. Biomed Res Int 2016; 2016: 8268569 . doi:10.1155/2016/8268569
24 Raghunathan K, Shaw A, Nathanson B. et al. Association between the choice of IV crystalloid and in-hospital mortality among critically ill adults with sepsis*. Crit Care Med 2014; 42: 1585-1591 . doi:10.1097/CCM.0000000000000305
25 Semler MW, Self WH, Wanderer JP. et al. Balanced crystalloids versus saline in critically ill adults. N Engl J Med 2018; 378: 829-839 . doi:10.1056/NEJMoa1711584
26 Finfer S, Bellomo R, Boyce N. et al. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med 2004; 350: 2247-2256 . doi:10.1056/NEJMoa040232
27 Patel A, Laffan MA, Waheed U. et al. Randomised trials of human albumin for adults with sepsis: systematic review and meta-analysis with trial sequential analysis of all-cause mortality. BMJ 2014; 349: g4561 . doi:10.1136/bmj.g4561
28 Perel P, Roberts I, Ker K. Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database Syst Rev 2013; 2: CD000567 . doi:10.1002/14651858.CD000567.pub6
29 Jiang L, Jiang S, Zhang M. et al. Albumin versus other fluids for fluid resuscitation in patients with sepsis: a meta-analysis. PLoS ONE 2014; 9: e114666 . doi:10.1371/journal.pone.0114666
30 Ferrer R, Mateu X, Maseda E. et al. Non-oncotic properties of albumin. A multidisciplinary vision about the implications for critically ill patients. Expert Rev Clin Pharmacol 2018; 11: 125-137 . doi:10.1080/17512433.2018.1412827
31 Semler MW, Rice TW. Sepsis resuscitation: fluid choice and dose. Clin Chest Med 2016; 37: 241-250 . doi:10.1016/j.ccm.2016.01.007
32 Moeller C, Fleischmann C, Thomas-Rueddel D. et al. How safe is gelatin? A systematic review and meta-analysis of gelatin-containing plasma expanders vs crystalloids and albumin. J Crit Care 2016; 35: 75-83 . doi:10.1016/j.jcrc.2016.04.011
33 Yealy DM, Kellum JA, Huang DT. et al. A randomized trial of protocol-based care for early septic shock. N Engl J Med 2014; 370: 1683-1693 . doi:10.1056/NEJMoa1401602
34 Mouncey PR, Osborn TM, Power GS. et al. Trial of early, goal-directed resuscitation for septic shock. N Engl J Med 2015; 372: 1301-1311 . doi:10.1056/NEJMoa1500896
35 Peake SL. ARISE Investigators, ANZICS Clinical Trials Group. et al. Goal-directed resuscitation for patients with early septic shock. N Engl J Med 2014; 371: 1496-1506 . doi:10.1056/NEJMoa1404380
36 Vignon P, Repesse X, Bégot E. et al. Comparison of echocardiographic indices used to predict fluid responsiveness in ventilated patients. Am J Respir Crit Care Med 2017; 195: 1022-1032 . doi:10.1164/rccm.201604-0844OC